Blog

Stephen D. Nimer’s recent study could lead to a new combination therapy for leukemia

Photo taken from Sylvester Comprehensive Cancer Center/X

May 23, 2024, 09:19

Stephen D. Nimer’s recent study could lead to a new combination therapy for leukemia

Sylvester Comprehensive Cancer Center shared a post on X:

“Stephen D. Nimer’s recent study could lead to a new combination therapy for leukemia. Featuring Sylvester’s collaboration with first author Hidehiro Itonaga, Ph.D., and other researchers, learn how the study could inform FDA development of new treatments.”

Read further.
Source: Sylvester Comprehensive Cancer Center/X
.

cancer cancer collaboration Cancer research Cancer Therapy Advancements combination therapy FDA development Hematology Hidehiro Itonaga Leukemia leukemia treatment Medical Research new treatments OncoDaily Oncology Stephen D. Nimer Sylvester collaboration Sylvester Comprehensive Cancer Center

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Bispecific Antibody M701 Offers a Novel Treatment Option for Malignant Ascites

Special Coverage